Drugs.com: Effect of cancer treatment on COVID-19 mortality
A UC study sheds light on death rates as they relate to patients with cancer and COVID-19
Cancer patients treated one to three months prior to COVID-19 diagnosis and those treated with chemoimmunotherapy have the highest 30-day mortality, according to a study presented at the annual meeting of the European Society for Medical Oncology, held virtually from Sept. 19 to 21.
Lead author Trisha Wise-Draper, MD, PhD, associate professor of medicine, UC Health oncologist and member of the UC Cancer Center, and colleagues examined outcomes related to systemic cancer treatment within one year of laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection.
Read the full Drugs.com/HealthDay News story.
Featured photo courtesy of the National Cancer Institute.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Supporters give generously to the Bearcats Pantry and Resource Center
December 22, 2025
Supporters gave generously to the Bearcats Pantry and Resource at the University of Cincinnati during two fundraisers: the Crosstown Foodout and Giving Tuesday.
Fusion reactors may be key to uncovering dark matter
December 22, 2025
Yahoo! News highlights a new study by University of Cincinnati physicist Jure Zupan that explains how fusion reactors might create subatomic particles associated with dark matter.
Challenges for veterans in the workforce
December 22, 2025
A new research review examines how veterans and their families impact the economy.